Standardized Bioflavonoid Composition for HMGB1 and NF-κB Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Aging leads to a decline in host defense mechanisms, characterized by immune senescence, oxidative stress, and increased levels of high-mobility group box protein 1 (HMGB1), which can result in severe inflammatory responses and conditions such as sepsis.
Innovation Solution
A bioflavonoid composition enriched with Free-B-Ring flavonoids and flavans, derived from Scutellaria baicalensis and Acacia catechu, respectively, which modulates HMGB1 and NF-κB signaling, reducing oxidative stress and enhancing mucosal immunity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If high concentrations of D-Galactose are used to induce aging model, then immune senescence and oxidative stress are accelerated, but excessive ROS and AGEs production occur leading to severe oxidative damage and cell apoptosis
Solution Approach 1:
The patent applies this principle by using the D-Galactose-induced oxidative stress model not just as a pathological condition to be avoided, but as a controlled experimental system to demonstrate the protective effects of bioflavonoids. The harmful ROS and AGEs production is converted into a beneficial demonstration platform for testing antioxidant and anti-glycation compounds, where the controlled damage allows clear observation of protective mechanisms.
Solution Approach 2:
The patent changes the concentration parameter of D-Galactose to optimize the aging model. By using high but controlled concentrations, the model achieves accelerated aging effects while remaining manageable. Additionally, the patent introduces bioflavonoid treatments that further modify the oxidative stress parameters, reducing ROS levels and AGEs formation while maintaining the accelerated aging context for effective intervention demonstration.
2Reliability
If HMGB1 is released from activated macrophages in response to inflammatory signals, then the host immune response is activated, but excessive HMGB1 release escalates the imbalance of host defense mechanism leading to multiple organ failure
Solution Approach 1:
The patent applies feedback control by monitoring HMGB1 release levels and implementing regulatory mechanisms through bioflavonoid intervention. The compounds act on the feedback loop by modulating macrophage activation and HMGB1 secretion, preventing the system from escalating to dangerous levels while maintaining adequate immune response. This creates a self-regulating host defense mechanism that responds to threats but automatically limits excessive inflammation.
Solution Approach 2:
The patent introduces bioflavonoids as intermediary substances that mediate between the immune threat detection and the HMGB1-mediated inflammatory response. These compounds act as molecular intermediaries that modulate the signaling pathways, allowing controlled immune activation while preventing the runaway inflammation that would otherwise lead to organ failure. The bioflavonoids serve as buffer intermediaries in the host defense system.
3Reliability
If pro-inflammatory cytokines are overproduced in response to infection, then the protective immune function is enhanced, but cytokine storm occurs causing injurious inflammatory response and acute systemic inflammatory syndrome
Solution Approach 1:
The patent applies this principle by implementing partial modulation of the cytokine response. Rather than completely suppressing the immune response or allowing full cytokine storm, the bioflavonoids provide partial control that achieves sufficient protective function while preventing harmful excess. This partial action approach maintains the beneficial aspects of immune activation while limiting the dangerous cytokine storm through moderate intervention.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The bioflavonoid composition effectively regulates host defense homeostasis, improving immune function, reducing inflammatory responses, and protecting respiratory and lung health from infections and air pollutants.
Implementation Method 1
Accumulation of these reactive oxygen species (ROS) and increased AGEs in this model would result in disequilibrium of normal organ and host defense homeostasis, which subsequently could cause oxidative stress
Implementation Method 2
HMGB1, is a critical mediator of sepsis as it is released from activated macrophages and monocytes in response to endogenous and exogenous inflammatory signals
Data Source
AI summary
Bioflavonoid compositions for establishment and regulation of homeostasis of host defense mechanism, are disclosed and comprise at least one standardized bioflavonoid extract enriched for at least one free-B-ring flavonoid and at least one standardized bioflavonoid extract enriched for at least one flavan. Contemplated compositions are effective for respiratory diseases and conditions.